Shifa

Staten Biotechnology

This company develops monoclonal antibody therapies for patients with dyslipidaemia to reduce cardiovascular risk and lower triglyceride levels.

ShouTi

This biopharmaceutical company develops oral small molecule therapeutics for patients with chronic metabolic, cardiovascular and pulmonary diseases.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

SFA Theraputics

This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.

NewAmsterdam Pharma

The company develops oral therapies to lower cholesterol in patients with cardiovascular disease whose symptoms are inadequately managed by standard statin treatments.

AnaCardio

This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.

Omthera Pharmaceuticals

This biopharmaceutical company develops omega-3 fatty acid therapies to treat patients with dyslipidemia and high triglyceride levels.

Eternygen

This biopharmaceutical company develops small molecule inhibitors targeting metabolic diseases, such as fatty liver and diabetes, for patients needing novel medical treatments.